BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma

被引：0
|
作者：
Christian Monnerat
Agnès Chompret
Caroline Kannengiesser
Marie-Françoise Avril
Nicolas Janin
Alain Spatz
Jean-Marc Guinebretière
Catalin Marian
Michel Barrois
Françoise Boitier
Gilbert M. Lenoir
Brigitte Bressac-de Paillerets
机构：
[1] Institut Gustave Roussy,Department of Genetics
[2] Institut Gustave Roussy,Oncological Genetics, Department of Medicine
[3] Institut Gustave Roussy,Department of Dermatology
[4] Institut Gustave Roussy,Department of Pathology
[5] CHU-Sart-Tilman,Service de Génétique
[6] Hôpital communal,Department of Dermatology
[7] Hôpital Cochin,Department of Pathology
[8] Centre René Huguenin,undefined
来源：
Familial Cancer | 2007年 / 6卷
关键词：
BRCA; TP53; CDKN2A; Melanoma; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 461
页数：8
相关论文
共 50 条
  • [21] Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma
    Katsama, A
    Sourvinos, G
    Zachos, G
    Spandidos, DA
    CANCER LETTERS, 2000, 150 (02) : 165 - 170
  • [22] Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients:: A population-based study
    de Sanjosé, S
    Léoné, M
    Bérez, V
    Izquierdo, A
    Font, R
    Brunet, JM
    Louat, T
    Vilardell, L
    Borras, J
    Viladiu, P
    Bosch, FX
    Lenoir, GM
    Sinilnikova, OM
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) : 588 - 593
  • [23] Breast surveillance of patients with BRCA1 and BRCA2 mutations
    Warner E.
    Current Breast Cancer Reports, 2013, 5 (3) : 255 - 261
  • [24] BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families
    Cherbal, Farid
    Bakour, Rabah
    Adane, Saida
    Boualga, Kada
    Benais-Pont, Gaelle
    Maillet, Philippe
    DISEASE MARKERS, 2010, 28 (06) : 377 - 384
  • [25] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    M J L Ligtenberg
    F B L Hogervorst
    H W Willems
    P J W Arts
    G Brink
    S Hageman
    E A J Bosgoed
    E Van der Looij
    M A Rookus
    P Devilee
    E M A W Vos
    G Wigbout
    P M Struycken
    F H Menko
    E J Th Rutgers
    E H Hoefsloot
    E C M Mariman
    H G Brunner
    L J Van’t Veer
    British Journal of Cancer, 1999, 79 : 1475 - 1478
  • [26] Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
    Ligtenberg, MJL
    Hogervorst, FBL
    Willems, HW
    Arts, PJW
    Brink, G
    Hageman, S
    Bosgoed, EAJ
    Van der Looij, E
    Rookus, MA
    Devilee, P
    Vos, EMAW
    Wigbout, G
    Struycken, PM
    Menko, FH
    Rutgers, EJT
    Hoefsloot, EH
    Mariman, ECM
    Brunner, HG
    Van't Veer, LJ
    BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) : 1475 - 1478
  • [27] BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela
    Lara, Karlena
    Consigliere, Nigmet
    Perez, Jorge
    Porco, Antonietta
    BIOLOGICAL RESEARCH, 2012, 45 (02) : 117 - 130
  • [28] A family with three germline mutations in BRCA1 and BRCA2
    Liede, A
    Metcalfe, K
    Offit, K
    Brown, K
    Miller, S
    Narod, SA
    Moslehi, R
    CLINICAL GENETICS, 1998, 54 (03) : 215 - 218
  • [29] The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas
    Akbari, M. R.
    Donenberg, T.
    Lunn, J.
    Curling, D.
    Turnquest, T.
    Krill-Jackson, E.
    Zhang, S.
    Narod, S. A.
    Hurley, J.
    CLINICAL GENETICS, 2014, 85 (01) : 64 - 67
  • [30] Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations
    Bayraktar, Soley
    Zhou, Jade Z.
    Bassett, Roland
    Barrera, Angelica M. Gutierrez
    Layman, Rachel M.
    Valero, Vicente
    Arun, Banu
    BREAST JOURNAL, 2020, 26 (08) : 1572 - 1582
12345